Midterms 2024: What the Results Mean for Health Care, MAHA, and Insurance

The 2024 midterm elections are set to reshape U.S. health policy, with implications for drug pricing, Medicare, Medicaid, and the broader insurance landscape. STAT's analysis highlights how the balance of power in Congress will influence key health care debates, including the future of the Inflation Reduction Act's drug pricing provisions and potential changes to the Affordable Care Act. The outcome could also impact the Make America Healthy Again (MAHA) movement, which has gained traction among some lawmakers seeking to overhaul public health agencies. For health insurers, the election results may determine the fate of enhanced subsidies that have expanded coverage under the ACA, with millions of Americans' premiums hanging in the balance. As new leadership takes the helm of key committees, stakeholders are bracing for shifts in oversight and legislative priorities. The stakes are high for patients, providers, and payers alike, as the next Congress will confront pressing issues like prescription drug costs, mental health parity, and pandemic preparedness. With divided government likely, bipartisan compromise will be essential to advance any meaningful health care legislation. The coming months will reveal whether lawmakers can bridge partisan divides to address the nation's most urgent health challenges.